Table 2.
Characteristic | Number (n = 9) |
---|---|
Median follow-up | 7 months (range, 3–12 months). |
Complete responsea | 7 (77.8%) |
Partial responsea | 2b (22.2%) |
Characteristics of tumors with PR | |
Location | Subcapsular [segment III (n = 1) and V (n = 1)] |
Size | 2.3 cm and 2.1 cm |
Adjuvant therapies for residual disease | |
|
1 (11.1%) |
|
1 (11.1%) |
PR, partial response; TACE, transarterial chemoembolization; PEI, percutaneous ethanol injection; modified RECIST, modified response evaluation criteria in solid tumors.
Based on modified RECIST at 1 month.12
Both were hepatocellular carcinoma.